PROSTATE-SPECIFIC ANTIGEN OBTAINED UNDER OPTIMAL CONDITIONS DETERMINES EXTRACAPSULAR ADENOCARCINOMA OF THE PROSTATE

被引:7
作者
EHRETH, JT
MILLER, JI
MCBEATH, RB
HANSEN, KK
AHMANN, FR
DALKIN, BL
SCHIFF, M
机构
[1] UNIV ARIZONA,HLTH SCI CTR,HEMATOL ONCOL SECT,TUCSON,AZ
[2] VET AFFAIRS MED CTR,TUCSON,AZ
[3] TUCSON MED CTR,TUCSON,AZ
来源
BRITISH JOURNAL OF UROLOGY | 1995年 / 75卷 / 01期
关键词
PROSTATE CANCER; ORGAN-CONFINED; PROSTATE-SPECIFIC ANTIGEN;
D O I
10.1111/j.1464-410X.1995.tb07226.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the relationship of prostate-specific antigen (PSA) obtained under optimal conditions with the presence or absence of organ-confined prostate cancer following radical prostatectomy. Patients and methods The medical records of 300 consecutive patients who underwent radical retropubic prostatectomy were retrospectively reviewed. Ninety-three patients were excluded who had a pre-operative PSA level potentially altered by various factors (prostate infection, manipulation or instrumentation). Results A pre-operative PSA value <4 ng/mL, accurately predicted pathologically confined disease in 42 of 51 patients (82%) which contrasted with extracapsular disease in 74 of 84 patients (88%) who had a PSA value >10 ng/mL. One of the 53 patients with a PSA >15 ng/mL had organ-confined disease at surgery. Conclusion These data demonstrate that optimal serum PSA values correlate well with pathological stage.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 20 条
  • [1] THE VALUE OF THE MEASUREMENT OF SERUM PROSTATE SPECIFIC ANTIGEN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND UNTREATED PROSTATE-CANCER
    ARMITAGE, TG
    COOPER, EH
    NEWLING, DWW
    ROBINSON, MRG
    APPLEYARD, I
    [J]. BRITISH JOURNAL OF UROLOGY, 1988, 62 (06): : 584 - 589
  • [2] BRAWER MK, 1988, ARCH PATHOL LAB MED, V112, P1110
  • [3] SCREENING FOR PROSTATIC-CARCINOMA WITH PROSTATE SPECIFIC ANTIGEN
    BRAWER, MK
    CHETNER, MP
    BEATIE, J
    BUCHNER, DM
    VESSELLA, RL
    LANGE, PH
    [J]. JOURNAL OF UROLOGY, 1992, 147 (03) : 841 - 845
  • [4] PROSTATIC SPECIFIC ANTIGEN AND PROSTATIC ACID-PHOSPHATASE IN THE MONITORING AND STAGING OF PATIENTS WITH PROSTATIC-CANCER
    ERCOLE, CJ
    LANGE, PH
    MATHISEN, M
    CHIOU, RK
    REDDY, PK
    VESSELLA, RL
    [J]. JOURNAL OF UROLOGY, 1987, 138 (05) : 1181 - 1184
  • [5] CLINICAL USE OF PROSTATE SPECIFIC ANTIGEN IN PATIENTS WITH PROSTATE-CANCER
    HUDSON, MA
    BAHNSON, RR
    CATALONA, WJ
    [J]. JOURNAL OF UROLOGY, 1989, 142 (04) : 1011 - 1017
  • [6] SERUM PROSTATE SPECIFIC ANTIGEN AS PRE-SCREENING TEST FOR PROSTATE-CANCER
    LABRIE, F
    DUPONT, A
    SUBURU, R
    CUSAN, L
    TREMBLAY, M
    GOMEZ, JL
    EMOND, J
    STAMEY, TA
    LANGE, PH
    [J]. JOURNAL OF UROLOGY, 1992, 147 (03) : 846 - 852
  • [7] LANGE PH, 1989, J UROLOGY, V141, P874
  • [8] LINDSTEDT G, 1990, CLIN CHEM, V36, P53
  • [9] PREOPERATIVE PREDICTION OF PATHOLOGICAL TUMOR VOLUME AND STAGE IN CLINICALLY LOCALIZED PROSTATE-CANCER - COMPARISON OF DIGITAL RECTAL EXAMINATION, TRANSRECTAL ULTRASONOGRAPHY AND MAGNETIC-RESONANCE-IMAGING
    MCSHERRY, SA
    LEVY, F
    SCHIEBLER, ML
    KEEFE, B
    DENT, GA
    MOHLER, JL
    [J]. JOURNAL OF UROLOGY, 1991, 146 (01) : 85 - 89
  • [10] PROSTATE SPECIFIC ANTIGEN IN THE PREOPERATIVE AND POSTOPERATIVE EVALUATION OF LOCALIZED PROSTATIC-CANCER TREATED WITH RADICAL PROSTATECTOMY
    OESTERLING, JE
    CHAN, DW
    EPSTEIN, JI
    KIMBALL, AW
    BRUZEK, DJ
    ROCK, RC
    BRENDLER, CB
    WALSH, PC
    [J]. JOURNAL OF UROLOGY, 1988, 139 (04) : 766 - 772